Page last updated: 2024-11-08

dimethylphenylpiperazinium iodide and Nutritional Disorders

dimethylphenylpiperazinium iodide has been researched along with Nutritional Disorders in 1 studies

Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with tetrodotoxin had no effect on the initial ISC, max but prevented its maintenance."1.29Neurally maintained hypersecretion in undernourished rat intestine activated by E. coli STa enterotoxin and cyclic nucleotides in vitro. ( Levin, RJ; Nzegwu, HC, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nzegwu, HC1
Levin, RJ1

Other Studies

1 other study available for dimethylphenylpiperazinium iodide and Nutritional Disorders

ArticleYear
Neurally maintained hypersecretion in undernourished rat intestine activated by E. coli STa enterotoxin and cyclic nucleotides in vitro.
    The Journal of physiology, 1994, Aug-15, Volume: 479 ( Pt 1)

    Topics: Animals; Atropine; Bucladesine; Cyclic GMP; Dimethylphenylpiperazinium Iodide; Enterotoxins; Escheri

1994